Clinical Trials

  • Cardiovascular Inflammation Reduction Trial (CIRT)

    A Randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate )LDM) in the prevention of cardiovascular events among stable coronary artery disease patients with type 2 diabetes or metabolic syndrome